MetalloDrugDB
MetalloDrugDB™
U.S. Patent-pending[1] Multi-Element Pharmaceutical Compound Database
What You Are Purchasing
The complete MetalloDrugDB — a proprietary database of 300 advanced multi-element coordination complexes designed for pharmaceutical applications. This is a structured database of metal-based therapeutic compounds.
A 2022 study published in Drug Discovery Today identified a shortage of comprehensive public metallodrug databases in the pharmaceutical sciences. MetalloDrugDB addresses that gap.
By The Numbers
| Metric | Value |
|---|---|
| Total Compounds | 300 |
| Therapeutic Categories | 15 |
| Elements Used | 43 |
| Scientific Cross-Reference Score | 80-87% |
| Databases Cross-Referenced | 10 |
| Patent Status | Filed (U.S. App. No. 19/630,444) |
| Priority Date | March 27, 2026 |
15 Therapeutic Categories
| Cat | Category | Compounds |
|---|---|---|
| A | Antimicrobial | 20 |
| B | Cardiovascular | 20 |
| C | Respiratory | 20 |
| D | Gastrointestinal | 20 |
| E | Analgesic & Anti-inflammatory | 20 |
| F | Endocrine | 20 |
| G | Neurological | 20 |
| H | Dermatological | 20 |
| I | Hematologic | 20 |
| J | Psychiatric | 20 |
| K | Renal & Hepatic | 20 |
| L | Immunological | 20 |
| M | Metabolic | 20 |
| N | Oncologic Support | 20 |
| O | Ophthalmic & Sensory | 20 |
What Makes This Valuable
- No Competition. No comparable metallodrug database of this scope is publicly documented.
- Patent Protected. U.S. Patent Application 19/630,444 covers compositions, synthesis methods, and therapeutic applications.
- Scientifically Validated. Cross-referenced against 10 major pharmaceutical databases including PubChem (119M compounds), ChEMBL (2.5M compounds), DrugBank, ClinicalTrials.gov, and more. Validation score: 80-87%.
- Market Context. Cisplatin alone (one platinum compound) generates billions annually and is used in 50-70% of all cancer treatment protocols. This database contains 300 compounds across 43 elements.
- Ready to Use. Complete synthesis parameters, elemental composition tables, molecular weights, and preparation notes for every compound.
What You Receive
- 300 complete compound formulations with full synthesis data
- U.S. Patent Application (assignable to buyer)
- Cross-Reference Validation Report with 30+ scientific citations
- 4 patent-quality technical drawings
- Master index and categorization system
- All source files and digital assets
- Executed Asset Purchase Agreement with Patent Assignment
Who Should Acquire This
- Pharmaceutical companies seeking new drug candidates
- Biotech startups building a compound pipeline
- Research institutions developing metal-based therapeutics programs
- Investment groups acquiring pharmaceutical IP assets
This is available for acquisition. Upon sale, all rights, patent ownership, and database assets transfer to the buyer via executed Asset Purchase Agreement.
Serious inquiries only. NDA available upon request.
Contact: crioneaka@outlook.com
Patent Application: 19/630,444 | Confirmation: 1348
MetalloDrugDB™ — 300 Compounds. 43 Elements. 15 Categories. One Database. First of Its Kind.
Acquisition Path
This product is available through CGB's 4-step acquisition path. The current price is shown in your cart and on the live storefront page.
- Step 1 — Proof of Function: public, $1.69 each.
- Step 2 — Mathematical Deposition: reading material under mutual NDA.
- Step 3 — Evaluation License: hands-on evaluation under NDA; fee credits toward Step 4.